Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Process for synthesizing antithrombin inhibitor of non-asymmetric non-peptide kind

An antithrombin, non-peptide technology, applied in the field of synthesis of new antithrombin inhibitors, can solve the problems of high price, low total yield, low yield, etc. high yield effect

Inactive Publication Date: 2006-11-15
FUDAN UNIV
View PDF0 Cites 65 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Utilize this method, start with the raw material 1 with higher price, have used N,N-dimethylformamide (DMF) that post-treatment is troublesome as solvent to synthesize compound 2; Compound 4 is synthesized compound 5 under the effect of CDI, And after acid hydrolysis of compound 5, add (NH 4 ) 2 CO 3 Compound 6 is obtained by ammoniation, and the two-step yield is low, which brings inconvenience to production
And the overall yield of this synthetic route is low (11.1%)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for synthesizing antithrombin inhibitor of non-asymmetric non-peptide kind
  • Process for synthesizing antithrombin inhibitor of non-asymmetric non-peptide kind
  • Process for synthesizing antithrombin inhibitor of non-asymmetric non-peptide kind

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Synthesis of ethyl 3-(pyridine-2-imine)-propionate (10)

[0040]Under nitrogen protection, add ethyl acrylate (27.5 g, 0.275 mol) to compound 9 (A=H, X=N)-2-aminopyridine (22.5 g, 0.25 mol), and stir and reflux at a temperature higher than 100 ° C for 24 h , the precipitate was filtered off, and the residue was concentrated and purified by a silica gel column to obtain a white solid 10 (38 g, 72%).

[0041] Synthesis of 1-(4-cyano-phenylimine)-acetic acid (12)

[0042] Add 150ml of water to compound 11 (6.0g, 0.05mol) and 1-chloroacetic acid (10g, 0.11mol) and heat to reflux until a large amount of yellow solid precipitates, filter at room temperature, and rinse with water, absolute ethanol, and anhydrous ether, respectively. After washing, yellow solid 12 (6.4 g, 73%) was obtained.

[0043] Synthesis of 4-aminomethyl-3-nitro-benzoic acid (1)

[0044] 150ml of 25%-30% methylamine aqueous solution was added to compound 13 (25g, 0.124mol), and the system was reacted at...

Embodiment 2

[0060] Synthesis of ethyl 3-(4-fluorophenyl-1-imine)-propionate (10')

[0061] Under nitrogen protection, ethyl acrylate (27.5 g, 0.275 mol) was added to compound 9'(A=F, X=H)-4-fluoroaniline (23.5 g, 0.25 mol), 10 ml of absolute ethanol and 10 ml of Tris Ethylamine was stirred and refluxed at higher than 100°C for 24h, the precipitate was filtered off, and the residue was concentrated and purified by a silica gel column to obtain a light red solid 10' (43g, 77%).

[0062] Synthesis of 3-[(4-aminomethyl-3-nitro-benzoyl)-(4-fluorobenzene)-2-imine]-propionic acid ethyl ester (3')

[0063] Compound 10' (10.5g, 0.05mol) was dissolved in 30ml CH 2 Cl 2 and 30ml triethylamine, slowly add the CH of compound 2 at room temperature 2 Cl 2 solution. The mixed system was reacted at room temperature for 12 h, the precipitate was filtered off, and the residue was concentrated and purified by a silica gel column to obtain a yellow oily liquid 3' (19.0 g, 98%).

[0064] Synthesis of 3-[...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A process for preparing the non-chiral non-peptide antithrombase depressants BIBR-953, BIBR-1048, etc from 3-nitro-4-chlorophenyl formic acid is disclosed. Said depressant contains 1,2,5-trisubstituted benzimdazole as central skeleton or a F atom.

Description

technical field [0001] The invention belongs to the field of chemical synthesis, and relates to a method for synthesizing inhibitors containing heterocyclic compounds, especially a novel antithrombin with 1,2,5-trisubstituted benzimidazole as the central skeleton or a fluorine atom Synthesis of Inhibitors. Background technique [0002] Thromboembolism is a leading cause of disease and death in Western societies. An important cause of this symptom is the overexpression of hemagglutination. Coagulation behavior involves two crucial steps, including: 1). Prothrombin complex activation generates thrombin; 2). Thrombin hydrolyzes fibrinogen to form insoluble fibrous coagulum. In addition, thrombin mediates platelet activation, which triggers a wide range of thrombogenic secondary effects, such as proliferation of vascular smooth muscle cells and fibroblasts, monocyte chemotaxis, and neutrophil adhesion. [0003] Current clinical anticoagulant therapy mainly includes the use of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/12
Inventor 林国强马景毅徐亮孙逊孙智华王进义
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products